Activity and Participation in Vestibular Disorders

Impairments and Personal Factors Associated With Activity and Participation in Vestibular Rehabilitation

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06271694

Acronym

APV

Enrollment

Registered

2024-02-22

Start date

2024-01-12

Completion date

2026-02-06

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Disorder

Keywords

Vestibular Rehabilitation, Activity and Participation

Brief summary

This study will examine whether impairments and personal factors are associated with activity and participation in people with vestibulopathy. Data collection will occur prior to starting vestibular rehabilitation and after completing vestibular rehabilitation.

Detailed description

Adults aged 18-years and older with symptomatic complaints of dizziness and/or imbalance and a medical diagnosis of unilateral vestibular hypofunction will be recruited at the time of their entry into vestibular rehabilitation. The investigators will analyze what factors (impairments and personal factors) are related to activity and participation in people with vestibular disorders and see if change in activity and participation is related to recovery from vestibulopathy.

Interventions

OTHERVestibular Rehabilitation

Standard vestibular rehabilitation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

\- 18-years and older with symptomatic complaints of dizziness and/or imbalance and a medical diagnosis of unilateral vestibular hypofunction

Exclusion criteria

* 1\. Cognition \<18 on Montreal Cognitive Assessment (MoCA) * 2\. Visual acuity worse than 20/40 with corrected lenses * 3\. Loss of protective distal sensation (defined as the inability to feel a 4.31 size monofilament on the plantar surface of the foot) * 4\. Inability to engage in community mobility

Design outcomes

Primary

Measure	Time frame	Description
Late-life Function and Disability Instrument	8-weeks	Activity and Participation (raw 16-80; scale 0-100 min-max scores); higher is better
Dizziness Handicap Inventory	8-weeks	Dizziness disability; 0-100 (min-max score); higher is greater disability.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBrooke Klatt, PhD

Assistant Professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026